| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |